cgs 15943 has been researched along with Constriction, Pathological in 1 studies
9-chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine: non-xanthine triazoloquinazoline adenosine antagonist
CGS 15943 : A member of the class of triazoloquinazolines that is [1,2,4]triazolo[1,5-c]quinazoline substited at positions 2, 5 and 9 by furan-2-yl, amino and chloro groups respectively. A potent antagonist at adenosine A1 and adenosine A2A receptors.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abels, BC | 1 |
| Callis, JT | 1 |
| Branch, RA | 1 |
| Sabra, R | 1 |
1 other study available for cgs 15943 and Constriction, Pathological
| Article | Year |
|---|---|
Influence of the adenosine receptor antagonist, CGS 15943A, on renal function after reconstruction of chronic renal artery stenosis in the dog.
Topics: Adenosine; Animals; Constriction, Pathologic; Creatinine; Dogs; Hemodynamics; Kidney; Purinergic Ant | 1992 |